Loading…

Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies

Loss of nuclear TDP-43 is a hallmark of neurodegeneration in TDP-43 proteinopathies, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). TDP-43 mislocalization results in cryptic splicing and polyadenylation of pre-messenger RNAs (pre-mRNAs) encoding stathmin-2 (also kno...

Full description

Saved in:
Bibliographic Details
Published in:Science (American Association for the Advancement of Science) 2023-03, Vol.379 (6637), p.1140-1149
Main Authors: Baughn, Michael W, Melamed, Ze'ev, López-Erauskin, Jone, Beccari, Melinda S, Ling, Karen, Zuberi, Aamir, Presa, Maximilliano, Gonzalo-Gil, Elena, Maimon, Roy, Vazquez-Sanchez, Sonia, Chaturvedi, Som, Bravo-Hernández, Mariana, Taupin, Vanessa, Moore, Stephen, Artates, Jonathan W, Acks, Eitan, Ndayambaje, I Sandra, Agra de Almeida Quadros, Ana R, Jafar-Nejad, Paayman, Rigo, Frank, Bennett, C Frank, Lutz, Cathleen, Lagier-Tourenne, Clotilde, Cleveland, Don W
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Loss of nuclear TDP-43 is a hallmark of neurodegeneration in TDP-43 proteinopathies, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). TDP-43 mislocalization results in cryptic splicing and polyadenylation of pre-messenger RNAs (pre-mRNAs) encoding stathmin-2 (also known as SCG10), a protein that is required for axonal regeneration. We found that TDP-43 binding to a GU-rich region sterically blocked recognition of the cryptic 3' splice site in pre-mRNA. Targeting dCasRx or antisense oligonucleotides (ASOs) suppressed cryptic splicing, which restored axonal regeneration and stathmin-2-dependent lysosome trafficking in TDP-43-deficient human motor neurons. In mice that were gene-edited to contain human cryptic splice-polyadenylation sequences, ASO injection into cerebral spinal fluid successfully corrected pre-mRNA misprocessing and restored stathmin-2 expression levels independently of TDP-43 binding.
ISSN:0036-8075
1095-9203
1095-9203
DOI:10.1126/science.abq5622